Journal of Skin and Stem Cell

Published by: Kowsar

Autoimmune Thyroid Disorders in Patients With Vitiligo

Abbas Zamanian 1 , Pezhman Mobasher 2 , * , Akram Ansar 2 , Shaghayegh Manuchehri 2 and Ghazaleh Ahmadi Jazi 2
Authors Information
1 Department of Dermatology, Iran University of Medical Sciences, Tehran, Iran
2 Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Journal of Skin and Stem Cell: October 1, 2014, 1 (2); e22113
  • Published Online: October 7, 2014
  • Article Type: Research Article
  • Received: July 16, 2014
  • Revised: September 6, 2014
  • Accepted: September 7, 2014
  • DOI: 10.17795/jssc22113

To Cite: Zamanian A, Mobasher P, Ansar A, Manuchehri S, Ahmadi Jazi G. Autoimmune Thyroid Disorders in Patients With Vitiligo, J Skin Stem Cell. 2014 ; 1(2):e22113. doi: 10.17795/jssc22113.

Copyright © 2014, Skin and Stem Cell Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Bolognia JL, Jorrizo JL, Rapini RP. Dermatology. 2008;
  • 2. Das SK, Majumder PP, Chakraborty R, Majumdar TK, Haldar B. Studies on vitiligo. I. Epidemiological profile in Calcutta, India. Genet Epidemiol. 1985; 2(1): 71-8[DOI][PubMed]
  • 3. Zamanian M, Azimian M. [prevalence of vitiligo in rural areas of Hamedan (Iran)in 2006]. Ir J dermatol. 2005; 5(1): 379-82
  • 4. Halioua B, Beumont MG, Lunel F. Quality of life in dermatology. Int J Dermatol. 2000; 39(11): 801-6[PubMed]
  • 5. Porter J. Personal Responses of Patients to Vitiligo. Arch Dermatol. 1978; 114(9): 1384[DOI]
  • 6. Jayaprakasam A, Darvay A, Osborne G, McGibbon D. Comparison of assessments of severity and quality of life in cutaneous disease. Clin Exp Dermatol. 2002; 27(4): 306-8[PubMed]
  • 7. Harlow D, Poyner T, Finlay AY, Dykes PJ. Impaired quality of life of adults with skin disease in primary care. Br J Dermatol. 2000; 143(5): 979-82[PubMed]
  • 8. Ravinder K, Daivinder P. Melanocytophagy and apoptosis in vitilligo. Indian J Dermatol Venereol. 2012; 78(1): 10-23
  • 9. James WD, Berge rTG, Elston DM. Andrew's Diseases Of The Skin. 2006;
  • 10. Iacovelli P, Sinagra JL, Vidolin AP, Marenda S, Capitanio B, Leone G, et al. Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo. Dermatology. 2005; 210(1): 26-30[DOI][PubMed]
  • 11. Dave S,, D'souza M, Thapp DM. High frequency of thyroid dysfunction in Indian patients with vitiligo. Indian J Dermatol. 2003; : 48-68
  • 12. Daneshpazhooh M, Mostofizadeh GM, Behjati J, Akhyani M, Robati RM. Anti-thyroid peroxidase antibody and vitiligo: a controlled study. BMC Dermatol. 2006; 6: 3[DOI][PubMed]
  • 13. Manighalam SH, Haji Abdolhamid M, Tousi P. association between vitiligoan thyroid dysfunction. Ir J Endocrinol Metab. 2002; 3(1): 165-8
  • 14. Vanderpump MPJ, Tunbridge WMG. The epidemiology of thyroid disease. The thyroid a fundamental and clinical text. 2000; : 487-73
  • 15. Arycan O, Koc K, Ersoy L. Clinical characteristics in 113 Turkish vitiligo patients. Acta Dermatovenerol Alp Pannonica Adriat. 2008; 17(3): 129-32[PubMed]
  • 16. Birlea SA, Fain PR, Spritz RA. A Romanian population isolate with high frequency of vitiligo and associated autoimmune diseases. Arch Dermatol. 2008; 144(3): 310-6[PubMed]
  • 17. Fernandes NC, Campos MM. Childhood vitiligo and thyroid disease. An Bras Dermatol. 2009; 84(2): 200-2[PubMed]
  • 18. Moradi S, Ghafarpoor G. Thyroid dysfunction and thyroid antibodies in Iranian patients with vitiligo. Indian J Dermatol. 2008; 53(1): 9-11[DOI][PubMed]
  • 19. Behl PN, Aggarwal A, Srivastava G. Practice of Dermatology. 2003; : 238-41
  • 20. Herane MI. Vitiligo and leukoderma in children. Clin Dermatol. 2003; 21(4): 283-95[PubMed]
  • 21. Jaigirdar MQ, Alam SM, Maidul AZ. Clinical presentation of vitiligo. Mymensingh Med J. 2002; 11(2): 79-81[PubMed]
  • 22. Engel L. What are those white patches on my patient's skin? Dermatol Nurs. 2001; 13(4): 292-7[PubMed]
  • 23. Lerner MR, Fitzpatrick TB, Halder RM, Hawk JL. Discussion of a case of vitiligo. Photodermatol Photoimmunol Photomed. 1999; 15(1): 41-4[PubMed]
  • 24. Nordlund JJ, Lerner AB. Vitiligo. It is important. Arch Dermatol. 1982; 118(1): 5-8[PubMed]
  • 25. Kumar V, Shankar V, Chaudhary S, Bhatia KK, Mehta LK, Arora N, et al. Radio-active iodine uptake in vitiligo. J Dermatol. 1990; 17(1): 41-3[PubMed]
  • 26. Hegedus L, Heidenheim M, Gervil M, Hjalgrim H, Hoier-Madsen M. High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm Venereol. 1994; 74(2): 120-3[PubMed]
  • 27. Zettinig G, Tanew A, Fischer G, Mayr W, Dudczak R, Weissel M. Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume? Clin Exp Immunol. 2003; 131(2): 347-54[PubMed]
  • 28. Majumder PP, Nordlund JJ, Nath SK. Pattern of familial aggregation of vitiligo. Arch Dermatol. 1993; 129(8): 994-8[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments